A 股每股派发现金红利人民币 0.48 元（含税）。 本次利润分配以实施权益分派股权登记日登记的总股本为基 数，具体日期将在权益分派实施公告中明确。 在实施权益分派股权登记日前总股本发生变动的，内蒙古伊利 实业集团股份有限公司（简称"公司"）拟维持每股分配比例不变，相 应调整分配总额，并将另行公告具体调整情况。 一、利润分配预案内容 根据公司 2025 年第三季度报告（未经审计），公司前三季度实现归 属于上市公司股东的净利润为 10,426,102,617.04 元，截至 2025 年 9 月 30 日，母公司报表未分配利润为 30,542,253,602.28 元。为进一步提升 对投资者的回报，结合公司盈利情况、业务发展资金需求等情况，公司 以实施权益分派股权登记日登记的总股本为基数，实施 2025 年中期利润 分配,本次利润分配方案如下： 公司拟向全体股东每股派发现金红利 0.48 元（含税），截至 2025 年 9 月 30 日，公司总股本 6,325,360,667 股，以此计算合计拟派发现金 红利总额为 3,036,173,120.16 元，占公司 2025 年前三季度合并报表归 属于母公司股东净利 ...

Core Points - The company reported a revenue of 28.564 billion yuan for Q3 2025, representing a year-on-year decline of 1.63% [1] - The net profit attributable to shareholders for Q3 2025 was 3.226 billion yuan, down 3.35% year-on-year [1] - Basic earnings per share for Q3 2025 stood at 0.51 yuan [1] - For the first three quarters of 2025, the company achieved a total revenue of 90.341 billion yuan, reflecting a year-on-year growth of 1.81% [1] - The net profit attributable to shareholders for the first three quarters was 10.426 billion yuan, which is a decline of 4.07% year-on-year [1] - Basic earnings per share for the first three quarters was reported at 1.65 yuan [1]

Financial Performance - The company's operating revenue for the third quarter was CNY 28,563,801,435.51, a decrease of 1.63% compared to the same period last year[4]. - The total profit for the quarter was CNY 3,606,149,140.23, down 3.77% year-on-year[4]. - The net profit attributable to shareholders was CNY 3,225,625,005.13, reflecting a decline of 3.35% compared to the previous year[4]. - The basic earnings per share for the quarter was CNY 0.51, a decrease of 1.92% year-on-year[4]. - Total operating revenue for the first three quarters of 2025 reached ¥90.56 billion, a slight increase from ¥89.04 billion in the same period of 2024, representing a growth of approximately 1.7%[17]. - Net profit for the first three quarters of 2025 was ¥10.42 billion, compared to ¥10.90 billion in 2024, indicating a decrease of about 4.3%[18]. - Operating profit for the first three quarters of 2025 was ¥12.32 billion, slightly down from ¥12.50 billion in 2024, reflecting a decrease of around 1.5%[17]. - The total comprehensive income for the first three quarters of 2025 was ¥11.16 billion, compared to ¥10.80 billion in 2024, indicating an increase of about 3.3%[18]. - Basic earnings per share for the first three quarters of 2025 were ¥1.65, slightly down from ¥1.71 in 2024, reflecting a decrease of about 3.5%[18]. Cash Flow and Investments - The net cash flow from operating activities for the year-to-date period decreased by 32.23%, amounting to CNY 9,399,863,342.62[4][7]. - The company experienced a significant decrease in cash received from sales, impacting the net cash flow from operating activities[7]. - Cash flow from operating activities for the first three quarters of 2025 was ¥9.40 billion, a significant decrease from ¥13.87 billion in 2024, representing a decline of about 32.5%[21]. - The net cash flow from investment activities was -15,609,791,873.63, a significant decrease compared to -5,076,062,812.82 from the previous period, indicating increased investment outflows[22]. - Cash inflow from financing activities totaled 152,860,917,055.23, while cash outflow was 158,251,039,299.71, resulting in a net cash flow of -5,390,122,244.48, slightly worse than -5,345,393,020.73 from the previous period[22]. - The company experienced a net cash outflow from financing activities of ¥10.20 billion in 2025, compared to a net outflow of ¥9.56 billion in 2024[29]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 152,726,359,994.44, a decrease of 0.65% from the end of the previous year[4]. - The company's current assets totaled RMB 67.66 billion, showing an increase from RMB 66.62 billion in the previous period[13]. - The company's total liabilities were RMB 92.48 billion, down from RMB 96.71 billion, reflecting a decrease of about 4.5%[14]. - Short-term borrowings increased to RMB 45.18 billion from RMB 36.35 billion, representing a rise of approximately 24.5%[14]. - The total assets increased to 143,021,438,411.37 from 133,370,151,846.58, reflecting a growth of approximately 7.3% year-over-year[24][25]. - Current assets rose to 54,314,693,266.71, up from 43,433,416,698.08, marking an increase of about 25%[24]. - The total liabilities reached 91,560,425,579.36, compared to 84,648,062,850.60, showing an increase of approximately 8.5%[25]. - The company's equity increased to 51,461,012,832.01 from 48,722,088,995.98, reflecting a growth of about 5%[25]. Research and Development - Research and development expenses increased to ¥627.68 million in 2025 from ¥556.31 million in 2024, marking an increase of approximately 12.8%[17]. - Research and development expenses increased to ¥526.18 million in the first three quarters of 2025, up from ¥481.43 million in 2024, marking a growth of 9.3%[27]. Shareholder Information - The top ten shareholders hold a combined total of 1,500,000,000 shares, representing approximately 23.73% of the total shares[9]. - The equity attributable to shareholders increased by 5.89% to CNY 56,310,618,404.84 compared to the end of the previous year[4]. - The total equity attributable to shareholders rose to RMB 56.31 billion from RMB 53.18 billion, marking an increase of about 5.4%[14]. Other Income and Expenses - Non-recurring gains and losses for the quarter totaled CNY 139,193,017.35, down from CNY 323,321,126.39 year-to-date[5]. - The company reported a decrease in sales expenses, which amounted to ¥16.55 billion in 2025 compared to ¥17.15 billion in 2024, a reduction of approximately 3.5%[17]. - The company reported a decrease in sales expenses to ¥14.09 billion in 2025 from ¥14.76 billion in 2024, a reduction of 4.5%[27]. - The company experienced a significant increase in other income, which rose to ¥741.99 million in 2025 from ¥734.38 million in 2024, a growth of approximately 1%[17]. - Total investment income for the first three quarters of 2025 was ¥3.94 billion, down from ¥5.89 billion in 2024, reflecting a decline of 33.2%[27]. Strategic Focus - The company continues to explore new product development and market expansion strategies to enhance its competitive position in the industry[15]. - The company's net profit for the first nine months of 2025 is yet to be disclosed, but previous trends indicate a focus on maintaining profitability amidst market fluctuations[15]. Accounting Standards - The company has not adopted new accounting standards for the year 2025[30].

证券代码：600887 证券简称：伊利股份 公告编号：临 2025-077 内蒙古伊利实业集团股份有限公司 关于取消监事会并修改《公司章程》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 内蒙古伊利实业集团股份有限公司（简称"公司"）于2025年10月29 日召开了第十一届董事会第八次会议及第十一届监事会第八次会议，审 议并通过了《公司关于取消监事会并修改<公司章程>的议案》。现对相 关事项公告如下： 为进一步完善公司治理结构，推动公司规范运作，根据《中华人民 共和国公司法》（简称"《公司法》"）、《上市公司章程指引》（简称"《章 程指引》"）等相关法律法规的规定，公司拟不再设置监事会，监事会的 职权由董事会审计委员会行使，相应废止《内蒙古伊利实业集团股份有 限公司监事会议事规则》，公司其他制度中涉及"监事会""监事"的相 关规定不再适用。 在公司股东大会审议通过取消监事会设置事项前，公司第十一届监 事会及监事仍将严格按照《公司法》《内蒙古伊利实业集团股份有限公司 章程》（简称"《公司章程》"）等相关规定的要求，勤勉尽 ...

证券代码：600887 证券简称：伊利股份 公告编号：临 2025-079 内蒙古伊利实业集团股份有限公司 关于 2025 年第三季度经营数据的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司行业信息披露指引第十四号——食 品制造（2022 年修订）》的相关规定，现将内蒙古伊利实业集团股份有 限公司 2025 年第三季度主要经营数据（未经审计）公告如下： 一、主营业务经营情况 | | 销售模式 | 2025 | 年 7-9 | 月 | 2025 年 1-9 月 | | --- | --- | --- | --- | --- | --- | | 经销 | | | 27,094,477,894.13 | | 86,451,848,878.36 | | 直营 | | | 1,191,870,271.31 | | 3,152,960,383.04 | | | 合计 | | 28,286,348,165.44 | | 89,604,809,261.40 | （三）主营业务收入按地区分部分类情况 单位：元 ...

证券代码：600887 证券简称：伊利股份 公告编号：临 2025-078 内蒙古伊利实业集团股份有限公司 关于召开2025年第一次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 股东大会召开日期：2025年11月28日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网 络投票系统 一、召开会议的基本情况 （一）股东大会类型和届次 2025年第一次临时股东大会 （二）股东大会召集人：公司董事会 （三）投票方式：本次股东大会所采用的表决方式是现场投票和网 络投票相结合的方式 （四）现场会议召开的日期、时间和地点 召开的日期时间：2025 年 11 月 28 日14 点 00 分 召开地点：呼和浩特市金川开发区金四路 8 号伊利全球人才发展中 心二楼会议室 重要内容提示： 不适用 （五）网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 11 月 28 日 至2025 年 11 月 28 日 采用上海证券交易所网络投票系统，通过交易系 ...

Market Overview - The beverage and dairy sector experienced a decline of 0.54% on the trading day, with Junyao Health leading the drop [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Stock Performance - Notable gainers in the beverage and dairy sector included: - Weiweijia (600300) with a closing price of 3.47, up 2.97% [1] - New Dairy (002946) at 17.01, up 2.47% [1] - Yili (600887) at 27.36, up 0.66% with a transaction volume of 621,200 shares and a transaction value of 1.702 billion [1] - Major decliners included: - Junyao Health (605388) at 7.13, down 3.52% [2] - Happy Home (300997) at 16.62, down 3.26% [2] - Beiyinmei (002570) at 6.28, down 2.64% with a transaction value of 305 million [2] Capital Flow - The beverage and dairy sector saw a net inflow of 193 million from institutional investors, while retail investors experienced a net outflow of 39.39 million [2] - The capital flow for key stocks showed: - Yili (600887) had a net inflow of 285 million from institutional investors, but a net outflow of 172 million from retail investors [3] - Chengde Lululemon (000848) had a net inflow of 42.62 million from institutional investors, with a net outflow of 5.37 million from retail investors [3] - Miao Ke Lan Duo (600882) had a net inflow of 20.36 million from institutional investors, but a significant net outflow of 29.61 million from retail investors [3]

Investment Rating - The report maintains a "Buy" rating for the company [4][10]. Core Views - The company's short-term performance continues to be under pressure, with distributors still in an adjustment phase. However, the current dividend payout ratio is favorable, and the report anticipates a recovery in the future [2][10]. - The report has revised the EPS forecasts for 2025-2027 to 0.52, 0.57, and 0.62 yuan respectively, down from previous estimates of 0.61, 0.66, and 0.70 yuan. The target price is set at 13.00 yuan per share, based on a 25x PE ratio for 2025E [10][12]. Financial Summary - Total revenue for 2023 is projected at 1,412 million yuan, with a slight increase of 0.6% from the previous year. However, a decline of 8.0% is expected in 2025 [3][11]. - Net profit attributable to the parent company is forecasted at 237 million yuan for 2023, with a year-on-year increase of 7.2%. The net profit is expected to decline to 204 million yuan in 2025, a decrease of 9.1% [3][11]. - The company’s net asset return rate is projected to be 13.9% in 2023, decreasing to 11.8% by 2025 [3][11]. Revenue and Profit Analysis - For the first three quarters of 2025, the company's revenue decreased by 8.51% year-on-year, while the net profit attributable to the parent company fell by 5.93% [10]. - In Q3 alone, revenue declined by 8.46% year-on-year, with a net profit margin of 14.71%, down 1.44 percentage points from the previous year [10]. Product and Channel Performance - The revenue from dairy beverages saw a significant decline of 13.22% to 88.7 million yuan in the first three quarters. Conversely, other products experienced rapid growth, increasing by 123.11% to 81.736 million yuan, driven by new products like vitamin water [10]. - The distribution channel revenue decreased by 10.74% to 90.1 million yuan, while direct sales channels grew by 37.08% to 68.059 million yuan, attributed to the rapid growth of e-commerce [10]. Dividend Policy - The company plans to distribute a cash dividend of 2.40 yuan per 10 shares for the first half of 2025, resulting in a total payout of 91.958 million yuan, with a dividend payout ratio of 95.67% [10].

Core Viewpoint - The aging population in China is driving growth in the senior nutrition market, but the industry faces challenges such as lack of standards and misleading product claims [2][4]. Industry Overview - The market for senior nutrition products is diverse, including supplements like protein powders and specialized milk powders, but many products do not meet the specific nutritional needs of the elderly [3][5]. - A report from ZhiShi Consulting indicates that the domestic nutrition health food market is expected to reach 522.3 billion yuan in 2024, with a compound annual growth rate of 8.5% for nutrition functional foods [5]. Regulatory Developments - The recent draft of the "National Food Safety Standard for Senior Nutritional Supplements" aims to establish clear definitions and standards for products targeting individuals over 60 years old [5][6]. - The draft specifies that quality protein content must not be less than 20% of the total product weight and outlines mandatory and optional nutrient components [6]. Market Challenges - The lack of stringent regulations has led to a proliferation of misleading marketing practices, causing distrust among elderly consumers regarding nutrition products [5]. - Industry experts emphasize the need for detailed standards to address the diverse range of functional products available in the market [6].

Core Viewpoint - The article discusses the challenges and opportunities in the elderly nutrition product market in China, highlighting the need for standardized regulations to address issues of product quality and consumer trust [3][6][8]. Group 1: Market Overview - The elderly nutrition product market is expected to experience significant growth due to the aging population, with a projected market size of 522.3 billion yuan in 2024 [8]. - The market for nutritional functional foods and health foods is estimated to reach 289.1 billion yuan and 233.1 billion yuan, respectively [8]. - The annual compound growth rate for nutritional functional foods is expected to be 8.5% over the next five years, surpassing the previous five-year rate of 6.6% [8]. Group 2: Current Challenges - The market is currently characterized by a lack of standards, leading to a mix of quality in elderly nutrition products, with some products not meeting the specific nutritional needs of older adults [6][9]. - Many products are marketed with exaggerated claims, creating a trust crisis among elderly consumers [8]. - The absence of specialized standards has allowed some companies to exploit loopholes, using general food standards to market products that should be classified as health foods [5][6]. Group 3: Regulatory Developments - A new national standard for elderly nutrition supplements has been proposed, which aims to define and regulate products specifically designed for individuals over 60 years old [8][9]. - The draft standard includes strict requirements for raw materials, such as a minimum of 20% high-quality protein content and restrictions on the use of hydrogenated fats [9]. - The introduction of this standard is seen as a crucial step towards improving product quality and shifting the industry from concept marketing to value-based supply [9].